网站首页 科室介绍 专家介绍 特色医疗 科普知识 科研工作 典型病例 医疗随访 器械与药品 科室园地
最新动态

 

2018第三届河南省血管外科学年会

 

2018年11月2日-11月4日

主办单位:河南省医学会

               河南省医学会血管外科学分会

 

 

联系我们
   
学术咨询
化 召 辉: 18239910816
刘 仕 睿: 13733826359
丁 鹏 绪: 13653865950
黄 必 润: 15738825673
曹      辉: 15713668997
门诊地址: 郑大一附院门诊楼6层27诊室
科室地址: 郑大一附院1号病房楼15层

欢迎您的咨询

当前位置: 主页 > 科研工作 >

近年我科发表文章3

时间:2015-04-04 10:06来源:郑大一附院 腔内血管外科 作者:腔内血管外科 点击:

1. Peng-Xu Ding, Zhen Li, Xin-Wei Han, Wen-Guang Zhang, Peng-Li Zhou, Zhong-Gao Wang. Portal, Mesenteric, and Splenic Vein Thromboses after Endovascular embolization for gastrointestinal bleeding caused by splenic arteriovenous fistula. Ann Vasc Sury, 2014 (Accepted)(通信作者)


2. Zhang WG, Zhen Li , Ding PX, Ren JZ, Ma J, Zhou PL, Wang ZG, Han XW.thrombosis. Ann Vasc Surg. 2014 Feb;28(2):491.e5-8 portal by caused vein portal the of transformation cavernous by complicated fistula arterioportal primary unusual an of treatment  Endovasculartechnique. Ann Vasc Surg. 2014 Jan;28(1):264.e13-6. (通信作者) stents kissing the using procedure Whipple a after stenosis bifurcation vein portal extrahepatic for treatment 


3. Zhang WG, Liu DM, Zhen Li, Wang YL, Ding PX, Zhou PL, Wang ZG, Han XW. Endovascularsyndrome.Ann Vasc Surg. 2014 Apr;28(3):742.e1-4. budd-Chiari in shunt portosystemic intrahepatic 


4. Ding PX, Zhen Li, Han XW, Zhang WG, Zhou PL, Wang ZG.Spontaneous


5. Wu JD, Zhen Li, Zhonggao Wang, Xinwei Han, Feng Ji, Wayne W. Zhang. Surgical and Endovascular Treatment of Severe Complications Secondary to Non-cirrhotic Portal Hypertension: Experience of 56 cases. Ann Vasc Surg.2013,27(4),441-446. (通信作者)follow-up.Ann Vasc Surg. 2012 Feb;26(2):277.e11-4. long-term with report case a syndrome: Budd-Chiari for shunt 


6. Zhang CC, Wang ZG, Li CM, Duan HY, Li JX, Gu YQ, Yu HX, Qi LX, Chen B, Zhen Li, Bian C.Mesocavoatrial


7.Chun-min Li,Zhong-gao Wang,Yong-quan Gu,Heng-xi Yu,Bing Chen,Zhen Li,Ce Bian. Management of complex patients with Budd-Chiari syndrome. Ann Vasc Surg,2010; 24(3): 301-307


8. Lai Yun-gang, Wang Zhong-gao, Ji-Feng, Wu Ji-ming, Chen Xiu, Zhen Li, Dong Shu-kui. Animal study for airway inflammation triggered by gastroesophageal reflux. Chinese Medical Journal, 2009,122(22):2775-2778.report. Int J Angiol. 2007 Winter;16(4):149-50. case - intestine the of hyperplasia produces insufficiency artery mesenteric 


9. Wang Z, Yu H, Gu Y, Li J, Zhang J, Zhen Li. Chronic


10. Zhonggao Wang, Zhenhai Yu, Zhen Li, Jiming Wu. Inferior vena cava-intrahepatic portal venous fistulas caused by cardiovascular foreign body. Rawal Med J. 2006;31(2):93-94


11. Zhonggao Wang, Xiu Chen, Zhen Li, Jiming Wu, Yahui Hu. Treating complicated patients with Budd-Chiari syndrome. J Gastroenterology and Hepatology. 2006;21(Supplement 6): A448 (abstract)


12. Yoshii T, Iwai M, Zhen Li, Chen R, Ide A, Fukunaga S, Oshita A, Mogi M, Higaki J, Horiuchi M. Regression of atherosclerosis by amlodipine via anti-inflammatory and anti-oxidative stress actions.Hypertension Res. 2006;29(6):457-66.


13. Lan Wu, Masaru Iwai, Zhen Li, Jian-Mei Li, Migi M, Masatsugu Horiuchi. Nifedipine inhibited angiotensin II-induced monocyte chemoattractant protein 1 expression: involvement of inhibitor of nuclear factor kappa B kinase and nuclear factor kappa B-inducing kinase. J Hypertension. 2006;24(1):123-30.


14.Masaru Iwai, Rui Chen, Zhen Li, Tetsuya Shiuchi, Jun Suzuki, Ayumi Ide, Masahiro Tsuda, Midori Okumura, Masaki Mogi, Masatsugu Horiuchi. Delation of angiotensin II type 2 receptor exaggerated atherosclerosis in Apolipoprotein E-null mice. Circulation. 2005; 112(11):1636-43.


15. Suzuki J, Iwai Massru, Zhen Li, Li JM, Min LJ, Ide A, Yoshii T, Oshita A, Mogi M and Masatsugu Horiuchi. Effect of combination of calcium antagonist, azelnidipine, and AT1 receptor blocker, olmesartan, on atherosclerosis in apolipoprotein E-deficient mice. J Hypertension.2005;23(7): 1383-9.


16.Zhen Li, Masaru Iwai, Lan Wu, Hong-Wei Liu, Rui Chen, Toyohisa Jinno, Jun Suzuki, Masahiro Tsuda, Midori Okumura, Tai-Xing Cui, Masatsugu Horiuchi. Fluvastatin Enhances the Inhibitory Effects of a Selective AT1 Receptor Blocker, Valsartan, on Atherosclerosis. Hypertension. 2004;44:758-763.


17. Lan Wu, Masaru Iwai, Zhen Li, Tetsuya Shiuchi, Li-Juan Min, Tai-Xing Cui, Jian-Mei Li, Midori Okumura, Clara Nahmias, and Masatsugu Horiuchi. Regulation of Inhibitory Protain-kB and Monocyte Chemoattractant Protain-1 by Angiotensin II Type 2 Receptor-Activated Src Homology Protain Tyrosine Phosphatase-1 in Fetal Vascular Smooth Muscle Cells. Molecular Endocrinology. 2004;18:666-678.


18. Toyohisa Jinno, Masau Iwai, Zhen Li, Jian-Mei Li, Tai-Xing Cui, Hiromi Rakugi, Toshio Ogihara, Masatsugu Horiuchi. Calcium Channel Blocker, Azelnidipine, Enhances Vascular Protective Effects of AT1 Receptor Blocker, Olmesartan. Hypertension. 2004;43:263-269.


19. Zhen Li, Masaru Iwai, Lan Wu, Tai-Xing Cui, Masatsugu Horiuchi. Role of AT2 Receptor in the Brain in Regulation of Blood Pressure and Water Intake:. Am J Physiol-Heart Circ Physiology. 2003; 284:H116-H121.


20. Masatsugu Horiuchi, Tai-Xing Cui, Zhen Li, Jian-Mei Li, Hironori Nakagami, Masaru Iwai.Fluvastatin Enhances the Inhibitory Effects of a selective AT1 Receptor Blocker, Valsartan, on Vascular Neointimal Formation. Circulation.2003;107: 106-112.


21.Lan Wu, Masaru Iwai, Hironori Nakagami, Zhen Li, Rui Chen, Jun Suzuki, Masahiro Akishita, Marc de Gasparo, Masatsugu Horiuchi. Roles of AT2 Receptor Stimulation Associated with Selective AT1 Receptor Blockade with Valsartan in the Improvement of Inflammation-induced Vacular Injury. Circulation. 2001;104:2716-2721.


22.Zhen Li, Zhonggao Wang, Bian Ce, Xiao-dong Chen, Jian-wen Li, Chen Xiu, Han Bing, Gao-Feng Hou, Chu Jian, Cui Qi. Interferon Regulatory Factor-1 Exerts Inhibitory Effect on Neointimal Formation After Vascular Injury. 中国医学科学杂志英文版. 2009;24(2):91-96(通信作者)


23. Zhen Li, Zhonggao Wang, Xiu Chen. The Inhibitory Effect of ATRAP, an AT1 Receptor-Associated Protein, on Vascular Smooth Muscle Cell Growth and Neointimal Formation. 中国医学科学杂志英文版. 2007;22:22-26(通信作者)


24.Wang Zhonggao,Wu Jimin, Li Zhen. Jugular Catheterized Derived Subclavian Pseudoaneurysm Treated with Percutaneous Injection of Thrombin. Journal of US-China Medical Science. 2007;4(1): 1-4


25. Zhonggao Wang, Zhen Li,Jimin Wu. Iatrogenic Sublavian pseudoaneurysm Treated with Percutaneous Injection of Thrombin. 血管外科. 2006;21: 55-58


26.Zhen Li, Zhonggao Wang, Xiaodong Chen. ATRAP, an AT1 Receptor-Associated Protein, Inhibited AT1 Receptor-Mediated Vascular Smooth Muscle Cell Growth and Neointimal Formation. 血管外科. 2006;22: 89-94


27. Zhen Li, Xiaodong Chen, Jianwen Li, Musheng Lin. The Inhibitory Effect of Olmesartan on MCP-1 and TNF-a Expression after Vascular Injury. Chin J Traaumatal (Eng Ed). 2004;7(1):56-60.中华创伤杂志英文版


28. Xiaodong Chen, Zhen Li, Jianwen Li. Anti-inflammatory effect of cerivastatin in vascular injury independent of serum cholesterol and blood pressure lowing effects in mouse model. Chin J Traaumatal (Eng Ed). 2002; 5(5): 294-298. 中华创伤杂志英文版(通信作者)


 

(责任编辑:腔内血管外科)
------分隔线----------------------------